FDA
-
-
-
-
-
-
-
Fresenius Medical Care Begins Broader U.S. Commercialization of 5008X™ CAREsystem, Achieves Key Milestones in Efforts to Introduce High-Volume Hemodiafiltration Dialysis Therapy to Individuals with
-
-
-
-
-
-
-
Fresenius Medical (FMS) Announces FDA Clearance of Versi®HD with GuideMe Software
-
-
-
-
-
-
-
Cara Therapeutics (CARA) Reports Ex-US Licensing Agreement with Vifor Fresenius Medical Care Renal Pharma to Commercialize KORSUVA Injection
-
-
-
-
-
-
-
C.R. Bard Inc. (BCR) Receives FDA Premarket Approval of LUTONIX 035 DCB as First and Only DCB for Treatment of Patients with Dysfunctional AV Fistulae
-
-
-
-
-
-
335,223 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


